2025-10-04 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc. (TDOC) based on the information provided.

**Report on Teladoc Health Inc. (TDOC)**

Teladoc Health Inc. provides virtual healthcare services, connecting patients with doctors and specialists remotely.

**1. Performance Analysis**

*   **Cumulative Returns:** TDOC: -56.65%, S&P 500 (VOO): 99.54%
*   **Relative Divergence:** TDOC is lagging significantly behind the S&P 500. The divergence range is wide (Min: -162.5, Max: 312.6, Current: -158.7, Relative: 0.8), indicating substantial underperformance. The current divergence is near the historical minimum.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
| :----------- | :------ | :------ | :------ | :----- | :------- |
| 2015-2017  | 77.0%  | 70.4%  | 51.0%  | -0.1  | 6.2    |
| 2016-2018  | 101.0% | 69.4%  | 86.0%  | -0.1  | 8.8    |
| 2017-2019  | 141.0% | 73.8%  | 118.0% | 0.3   | 14.8   |
| 2018-2020  | 105.0% | 80.9%  | 81.0%  | 0.3   | 35.3   |
| 2019-2021  | -78.0% | 80.9%  | -125.0% | 0.3   | 16.2   |
| 2020-2022  | -252.0% | 85.9%  | -251.0% | -0.9  | 4.2    |
| 2021-2023  | -315.0% | 85.9%  | -316.0% | -1.8  | 3.8    |
| 2022-2024  | -93.0%  | 85.9%  | -113.0% | -1.9  | 1.6    |
| 2023-2025  | -28.0%  | 81.6%  | -91.0%  | -0.8  | 1.6    |

*   **Analysis:**
    *   **CAGR:**  Steep declines in recent periods.
    *   **MDD:** High Maximum Drawdown indicating significant risk and volatility.
    *   **Alpha:**  Consistently negative Alpha suggests underperformance relative to a benchmark, especially in recent years.
    *   **Beta:**  The Beta values have been fluctuating and mostly negative in recent years, suggesting that the stock's price movements are less correlated with the overall market, and when correlated, they tend to move in the opposite direction.
*   **Cap(B):**  Teladoc's market capitalization has decreased from 6.2 Billion to 1.6 Billion from 2015 to now, which suggests that Teladoc's business is not as strong as it used to be.

**2. Recent Stock Performance**

*   **Current Price:** 9.01
*   **Last Market Change:** Price: 9.01, Previous Close: 8.48, Change: +6.25% (Significant increase)
*   **Moving Averages:**
    *   5-day MA: 8.173
    *   20-day MA: 8.0105
    *   60-day MA: 7.7514

**Analysis:** The stock price is above all three moving averages, indicating a short-term upward trend. The significant price increase of 6.25% compared to the previous close suggests a recent positive catalyst.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 67.87 (Approaching overbought territory)
*   **PPO:** 0.67
*   **Hybrid Signal:** Cash 0%, Buy 100% (110 shares - Very Safe)
*   **Recent (20-day) Relative Divergence Change:** +0.4 (Short-term increase)
*   **Expected Return:** -9445.0% (Significant underperformance relative to S&P 500 in the long term)

**Analysis:** Despite the "High Investment Recommended" MRI, the extremely negative expected return raises serious concerns about long-term profitability. The RSI approaching overbought territory could signal a potential pullback. The positive change in relative divergence suggests recent relative strength, but it's important to consider this in the context of the overall underperformance.

**4. Recent News & Significant Events**

*   **[2025-10-03]** Why Teladoc Health Stock Jumped 15% This Morning (Motley Fool)
*   **[2025-10-03]** Short Sellers Survive a Tough Tape, Believing Their Day Will Come (Barrons.com)
*   **[2025-10-02]** Etsy, Snap, The RealReal, Instacart, and Teladoc Shares Skyrocket, What You Need To Know (StockStory)
*   **[2025-10-02]** 3 Small-Cap Stocks That Concern Us (StockStory)
*   **[2025-10-01]** Down 96% From Its Highs, Is Teladoc a Hidden Bargain or a Value Trap? (Motley Fool)
*   **[2025-09-30]** Etsy, Bumble, Skillz, Teladoc, and Reddit Stocks Trade Down, What You Need To Know (StockStory)

**Analysis:** The news headlines present a mixed picture. The recent jump in stock price is a positive development, but the presence of articles questioning its long-term value ("Value Trap?") and concerns from short sellers suggest caution. It is important to find out what has caused the 15% increase in price this morning. The stock seems to be volatile.

**4-2. Analyst Opinions**

*   **Consensus:** Hold (Mean: 2.64)
*   **Target Price:** Average: 9.12, High: 12.00, Low: 7.00
*   **Analysis:** Analyst consensus is neutral (Hold), with the average target price slightly above the current price. This suggests limited upside potential in the near term, according to analysts.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출      |
| :--------- | :----- | :-------- |
| 2025-07-30 | -0.19  | 0.63 B$ |
| 2025-05-01 | -0.53  | 0.63 B$ |
| 2024-10-31 | -0.19  | 0.64 B$ |
| 2024-08-01 | -4.92  | 0.64 B$ |
| 2025-07-30 | -4.92  | 0.64 B$ |

**Analysis:** The company is consistently reporting negative EPS, indicating a lack of profitability. Revenue has remained relatively stable.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| :--------- | :-------- | :------------ |
| 2025-06-30 | $0.63B    | 69.85%        |
| 2025-03-31 | $0.63B    | 68.73%        |
| 2024-12-31 | $0.64B    | 70.50%        |
| 2024-09-30 | $0.64B    | 71.94%        |
| 2024-06-30 | $0.64B    | 70.73%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
| :--------- | :-------- | :-------- |
| 2025-06-30 | $1.42B    | -2.30%    |
| 2025-03-31 | $1.43B    | -6.52%    |
| 2024-12-31 | $1.49B    | -3.25%    |
| 2024-09-30 | $1.51B    | -2.21%    |
| 2024-06-30 | $1.50B    | -55.77%   |

**Analysis:** Profit Margins are relatively high but ROE is negative, this discrepancy is happening because Teladoc is not profitable in the income statement. Equity has slightly decreased over the past few quarters.

**7. Overall Assessment**

Teladoc Health Inc. (TDOC) presents a concerning picture.

*   **Poor Performance:** It has significantly underperformed the S&P 500.
*   **Negative Profitability:**  The company is not profitable, as reflected in negative EPS and ROE.
*   **Mixed Signals:** While there was a recent price jump and the MRI suggests "High Investment Recommended," the negative expected return and analyst concerns warrant caution.
*   **Risk Factors:** High volatility (MDD) and a negative Beta in recent periods indicate a risky investment.

**Recommendation:**

Based on the data, **caution is advised** regarding investing in TDOC. The recent price increase may be a short-term phenomenon. A potential investor should conduct thorough due diligence, carefully consider their risk tolerance, and closely monitor the company's progress towards profitability before making any investment decisions. The news headlines regarding the "Value Trap?" and short seller activity should be carefully investigated.
